Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Name: Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
License: Public Domain

Ludwig Institute for Cancer Research

ClinicalTrials.gov · Datasets · License: Public Domain

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 146438
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.